Evogene Ltd.
EVGN
$1.06
$0.010.47%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.46M | 427.00K | -7.63M | -5.42M | -3.98M |
| Total Depreciation and Amortization | 290.00K | 593.00K | 209.00K | 60.00K | 661.00K |
| Total Amortization of Deferred Charges | 330.00K | 334.00K | 137.00K | -- | -- |
| Total Other Non-Cash Items | 555.00K | -6.00M | 2.16M | -248.00K | 530.00K |
| Change in Net Operating Assets | 986.00K | -562.00K | -447.00K | 152.00K | -1.52M |
| Cash from Operations | -2.30M | -5.21M | -5.58M | -5.46M | -4.32M |
| Capital Expenditure | -2.00K | -322.00K | -137.00K | -25.00K | -216.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | -- | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -987.00K | 9.08M | 2.15M | 3.24M | 3.86M |
| Cash from Investing | -989.00K | 8.76M | 2.02M | 3.21M | 3.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -137.00K | -206.00K | -106.00K | -239.00K | -211.00K |
| Issuance of Common Stock | 4.28M | 646.00K | 5.54M | 83.00K | 8.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.00K | 0.00 | -50.00K | 5.00K | -58.00K |
| Cash from Financing | 4.15M | 440.00K | 5.38M | -151.00K | 7.80M |
| Foreign Exchange rate Adjustments | 45.00K | -7.00K | 11.00K | -35.00K | -28.00K |
| Miscellaneous Cash Flow Adjustments | -70.00K | -- | -- | -- | -- |
| Net Change in Cash | 834.00K | 3.98M | 1.83M | -2.43M | 7.10M |